Matteo Bottai

Matteo Bottai

Professor
Telephone: +46852487024
Visiting address: Nobels väg 13, 17177 Stockholm
Postal address: C6 Institutet för miljömedicin, C6 Biostatistik Bottai, 171 77 Stockholm

About me

  • Matteo Bottai, Sc.D., is Professor of Biostatistics, Head of the Division of Biostatistics, and the Director of the Biostatistics Core Facility at Karolinska Institutet, He is also a Guest Professor at the Division of Mathematical Statistics at Stockholm University and Adjunct Professor at the Division of Biostatistics at the University of South Carolina. He received his doctoral degree from Harvard University, USA.

    He has coauthored numerous papers in theoretical statistics, (e.g. Annals of Statistics, Bernoulli, Biometrika, Journal of the American Statistical Association), statistical methods (e.g. Biometrics, Biostatistics, Statistics in Medicine, Statistical Methods in Medical Research), computational statistics (e.g. Journal of Statistical Computation and Simulation, Stata Journal), epidemiology (e.g. American Journal of Epidemiology, Epidemiology, European Respiratory Journal), and medicine (e.g. British Medical Journal, Heart, Environmental Health Perspectives). He has served as Editor-in-Chief of Open Statistics in other capacities for several other statistical and medical journals (e.g. American Journal of Epidemiology, Biometrics, Journal of the American Statistical Association, Journal of the Royal Statistical Society B, Journal of Multivariate Analysis).

    His current research focuses on statistical methods for inference on quantiles (e.g. parametric quantile process models, linear quantile mixed models, logistic quantile regression) and risk modeling. He served as Head of the Division of Biostatistics and member of the Faculty Senate at the University of South Carolina, and President of the South Carolina Chapter of the American Statistical Association. He was a recipient of the Fulbright Scholarship and of three Visiting Professor Awards. He is an elected member of the Delta Omega Honorary Society in Public Health.

    Education
    Doctor of Science, Harvard University

Selected publications

Articles

All other publications

Grants

  • Swedish Heart-Lung Foundation
    1 January 2023 - 31 December 2025
    Background: Cardiovascular diseases (CVD) are responsible for almost one third of the deaths worldwide. Individuals with mental disorders have shown to be a group particularly vulnerable to suffer from CVD. For example, using data from the Swedish registers, our team has established that individuals with obsessive-compulsive disorder (OCD), an impairing disorder affecting about 2% of the population, have an increased risk of obesity, type 2 diabetes, circulatory system diseases, and specific CVDs, with the subtypes venous thrombo-embolism and heart failure being the most relevant. We have also established that these risks in OCD are likely to be a consequence of the disorder itself, rather than attributable to familial factors or medication. Given this, it is crucial to consider lifestyle habits (e.g., physical activity, diet) which may be responsible for the observed CVD risks and are known to be amenable to modification. Objectives: This project is a collaboration between Karolinska Institutet, the Department of Cardiology at Karolinska Universitetssjukhuset, and the specialist OCD and related disorders clinic at Psykiatri Sydväst, Region Stockholm. With the help and support of the Swedish OCD association (Svenska OCD-förbundet), we have developed a lifestyle intervention to reduce metabolic and cardiovascular risk factors in individuals with OCD, which we aim to evaluate in this project. Workplan: We will follow a two-step approach. First, we will conduct a pilot study to test whether our lifestyle intervention, including physical exercise, modification of dietary habits, and other behavioural changes is feasible, safe, and acceptable for the participants. Second, we will conduct a fully powered randomized controlled trial to establish the efficacy of this intervention, compared to medical advice and treatment as usual. We will also evaluate whether this intervention is cost-effective from a societal perspective. Meaning: Our results have the potential to prevent and reduce the cardiometabolic outcomes observed in individuals with OCD. If the lifestyle intervention program proves to be successful in reducing this risk and does so in a cost-effective manner, we will aim to implement the intervention in routine clinical care. Additionally, the intervention could be expanded to individuals with other common mental disorders, such as anxiety and depression, as well as other groups at risk.
  • Swedish Research Council for Environment Agricultural Sciences and Spatial Planning
    1 January 2023 - 31 December 2025
    Cardiovascular and metabolic diseases (CMD) remain the leading cause of morbidity and mortality globally, including myocardial infarction, stroke and type 2 diabetes. Although young people are not typically affected by CMD, the risk factors for these conditions are present during the early years of life, affecting long-term disease risk and the disease burden in the adulthood. Air pollution, transportation noise, and greenness are among the modifiable risk factors that may influence cardiometabolic health. Previous research on causes of CVD often focuses on single risk factors while effects from multiple environmental exposures in young adults are understudied. This project aims to investigate how air pollution, transportation noise and neighborhood greenness contribute to the development of a wide range of early markers of CMD and to elucidate characteristics that may modify the relation between environmental exposures and CMD traits. The project will be based on the prospective population-based birth cohort BAMSE comprising 4000 individuals followed from birth up to young adulthood with repeated questionnaires and extensive clinical investigations. Exposure to environmental factors is estimated based on residential address history. The results of the project will serve as a basis for policy makers in decision making processes, particularly related to environmental policies and urban planning as well as for individual risk assessment and prevention in clinical practice.
  • Swedish Research Council for Health Working Life and Welfare
    1 November 2022 - 30 September 2026
    Research problem / specific questions Autism Spectrum Disorders (ASD) are neurodevelopmental disorders associated with life-long struggles and high societal costs affecting about 2% of all children and adults. A large majority of young people with autism have comorbid mental disorders, such as obsessive-compulsive disorder (OCD), which are potentially treatable. However, these treatments are rarely available because they require access to highly specialised clinics. The families of children with ASD demand more access to treatment for these comorbidities. Access to specialist treatment could be improved dramatically if routine aspects of treatment could be digitalised. The overarching purpose of this project is to co-develop and evaluate the efficacy and cost-effectiveness of a novel digital intervention for OCD in young people with autism, and to follow through with a nationwide implementation of the intervention.  Data and method We propose to partner with patients, families, and clinicians to develop a novel digital intervention and evaluate its efficacy and cost-effectiveness in a fully powered multicentric (Stockholm, Lund, Gothenburg) randomised controlled trial (N=220), comparing our novel digital intervention with an active comparator. Next, we will implement the intervention in the national Stöd och Behandling digital platform and will conduct a real-world evaluation of the intervention in the same three clinics.  Plan for project realisation The project brings together a multidisciplinary team of researchers with a track record in child and adolescent psychiatry, clinical trials, digital interventions, biostatistics, health economics, and implementation science. The team also includes service users and patient organisations that will contribute with their lived experience, as well as health professionals.  RelevanceThis project originated as a direct response to a demand from families who have children with ASD. This will be the first properly powered trial of a digital intervention for a comorbid psychiatric disorder in autistic children anywhere, and the first to conduct a health economic evaluation. This will also be a rare example of national implementation of a digital intervention for youth with mental health problems and of a formal evaluation of the implementation. If successful, this project could represent a new model for the development and implementation of digital interventions for a broader range of comorbidities in youth with ASD.
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2020 - 31 December 2022
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2018 - 31 December 2020
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2017 - 31 December 2022
  • Swedish Research Council for Environment Agricultural Sciences and Spatial Planning
    1 January 2012 - 31 December 2012

Employments

  • Professor, Institute of Environmental Medicine, Karolinska Institutet, 2010-

News from KI

Events from KI